장골 스텐트 시장 보고서 : 동향, 예측 및 경쟁 분석(2035년)

The future of the global iliac stent market looks promising with opportunities in the hospital and outpatient facility markets. The global iliac stent market is expected to reach an estimated $2.3 billion by 2035 with a CAGR of 5.5% from 2026 to 2035. The major drivers for this market are the increasing prevalence of peripheral artery diseases, the rising demand for minimally invasive treatments, and the growing adoption of advanced stent technologies.

• Lucintel forecasts that, within the type category, self-expandable stent is expected to witness higher growth over the forecast period.
• Within the end use category, outpatient facility is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Iliac Stent Market

The iliac stent market is experiencing rapid evolution driven by technological advancements, increasing prevalence of peripheral artery disease, and a growing emphasis on minimally invasive procedures. As healthcare providers seek more effective and durable solutions, market players are innovating to meet these demands. The integration of new materials, improved stent designs, and personalized treatment options is shaping the future landscape. Additionally, regulatory changes and rising healthcare expenditure are influencing market dynamics. These developments collectively contribute to a more competitive, innovative, and patient-centric market environment, ultimately improving clinical outcomes and expanding access to advanced vascular interventions.

• Technological Innovation: The market is witnessing significant advancements in stent design and materials, such as bioresorbable and drug-eluting stents. These innovations aim to improve patency rates, reduce restenosis, and enhance biocompatibility. Enhanced imaging and delivery systems are also making procedures more precise and less invasive. This trend is driving the development of next-generation iliac stents that offer better durability, flexibility, and patient outcomes, thereby expanding the scope of minimally invasive vascular interventions.
• Rising Prevalence of Peripheral Artery Disease: An increase in PAD cases globally, driven by aging populations, diabetes, and lifestyle factors, is fueling demand for iliac stents. As more patients require revascularization procedures, the market expands. This trend underscores the need for durable, effective stent solutions that can address complex lesions and improve quality of life. The growing patient pool is also encouraging healthcare providers to adopt advanced stenting techniques, further propelling market growth.
• Adoption of Minimally Invasive Procedures: The shift from traditional open surgeries to minimally invasive endovascular techniques is a key trend. Iliac stenting offers reduced recovery times, lower complication rates, and less procedural discomfort. This trend is supported by technological improvements in imaging and delivery systems, making procedures safer and more accessible. As patient preference and clinical guidelines favor minimally invasive options, the market for iliac stents is expected to grow steadily, with increased adoption across healthcare settings.
• Regulatory and Reimbursement Changes: Evolving regulatory standards and reimbursement policies are impacting market dynamics. Stricter approval processes for new stent devices are encouraging innovation but may also pose challenges for market entry. Conversely, favorable reimbursement policies are incentivizing healthcare providers to adopt advanced stenting solutions. These regulatory and financial factors influence product development, pricing strategies, and market accessibility, shaping the competitive landscape and encouraging companies to focus on compliance and value-based care.
• Market Expansion and Geographic Growth: Emerging markets in Asia-Pacific, Latin America, and the Middle East are experiencing increased healthcare infrastructure development and rising awareness about vascular diseases. This expansion offers significant growth opportunities for iliac stent manufacturers. Local manufacturing, strategic partnerships, and tailored product offerings are facilitating market penetration in these regions. As healthcare access improves and economic conditions stabilize, these markets are expected to contribute substantially to global market growth, diversifying the competitive landscape and fostering innovation.

In summary, these trends are collectively transforming the iliac stent market by fostering innovation, expanding access, and improving patient outcomes. The focus on technological advancements, demographic shifts, procedural preferences, regulatory landscapes, and geographic expansion is creating a dynamic environment that is poised for sustained growth and evolution.

Recent Developments in the Iliac Stent Market

The iliac stent market is experiencing rapid growth driven by technological advancements, increasing vascular disease prevalence, and expanding healthcare infrastructure worldwide. Innovations in stent design and materials are improving patient outcomes, while rising awareness and screening programs are boosting demand. Additionally, strategic collaborations and regulatory approvals are facilitating market expansion. The markets evolution reflects a focus on minimally invasive procedures and personalized treatments, positioning it for sustained growth. These developments are reshaping the landscape, offering new opportunities for stakeholders and improving patient care globally.

• Innovation in Stent Technology: The development of advanced iliac stents with improved flexibility, durability, and biocompatibility is transforming treatment options. New materials and design enhancements reduce restenosis and complications, leading to better long-term outcomes. This innovation attracts healthcare providers seeking effective, minimally invasive solutions, thereby expanding market reach. As research continues, the integration of drug-eluting and bioresorbable stents is expected to further revolutionize the market, offering tailored therapies for diverse patient needs.
• Increasing Prevalence of Vascular Diseases: The rising incidence of peripheral artery disease and atherosclerosis globally is significantly driving iliac stent demand. Aging populations and lifestyle factors contribute to vascular health issues, prompting more interventions. Early diagnosis and improved screening programs are identifying candidates for stenting procedures, expanding the patient base. This trend underscores the need for accessible, effective treatment options, fueling market growth and encouraging manufacturers to innovate and scale production.
• Expanding Healthcare Infrastructure: Growth in healthcare facilities, especially in emerging economies, is facilitating wider access to vascular interventions. Investments in hospitals and clinics equipped with advanced diagnostic and surgical tools are increasing procedural volumes. Government initiatives and public-private partnerships are further supporting infrastructure development. This expansion enhances the availability of iliac stent procedures, reduces treatment costs, and accelerates market penetration, ultimately improving patient outcomes and fostering industry growth.
• Strategic Partnerships and Regulatory Approvals: Collaborations between medical device companies and healthcare providers are accelerating product development and commercialization. Regulatory approvals in key markets, such as the U.S. and Europe, are enabling wider adoption of innovative stents. These strategic moves streamline market entry, ensure compliance, and boost consumer confidence. As approvals and partnerships multiply, the market benefits from a broader portfolio of advanced devices, increasing competition, and driving innovation to meet diverse clinical needs.
• Rising Demand for Minimally Invasive Procedures: The shift towards less invasive treatments is a key driver in the iliac stent market. Patients prefer procedures with shorter recovery times and fewer complications, prompting clinicians to adopt endovascular techniques. This demand encourages manufacturers to develop user-friendly, high-performance stents compatible with minimally invasive approaches. The trend enhances procedural success rates and patient satisfaction, leading to increased adoption and market expansion, especially in outpatient and outpatient-like settings.

These developments collectively are propelling the iliac stent market towards significant growth. Technological innovations, rising disease prevalence, infrastructure expansion, strategic collaborations, and patient preferences for minimally invasive procedures are creating a dynamic environment. This evolution is not only expanding market size but also improving treatment outcomes and accessibility. As these factors continue to evolve, the market is poised for sustained growth, offering promising opportunities for industry stakeholders and better healthcare solutions for patients worldwide.

Strategic Growth Opportunities in the Iliac Stent Market

The iliac stent market is experiencing significant growth driven by increasing peripheral artery disease cases, technological advancements, and expanding healthcare infrastructure. Rising awareness and demand for minimally invasive procedures further propel market expansion. Key applications across various medical settings are creating new opportunities for manufacturers and healthcare providers. Strategic investments and innovation are essential to capitalize on these trends, ensuring improved patient outcomes and market competitiveness. This dynamic environment offers substantial potential for growth, making it a critical focus for stakeholders aiming to enhance vascular intervention solutions.

• Increasing Prevalence of Peripheral Artery Disease: The rising incidence of peripheral artery disease (PAD) globally is a primary driver for iliac stent adoption. As PAD progresses, patients require minimally invasive interventions like iliac stenting to restore blood flow. The aging population and lifestyle-related risk factors contribute to this trend, expanding the patient pool. Healthcare providers are increasingly opting for iliac stents over traditional surgery due to reduced recovery times and improved outcomes, fueling market growth.
• Advancements in Stent Technology and Materials: Innovations in stent design, such as drug-eluting and bioresorbable stents, are enhancing treatment efficacy and patient safety. New materials improve flexibility, durability, and biocompatibility, reducing complications like restenosis. These technological advancements enable more precise placement and longer-lasting results, encouraging wider adoption. Continuous R&D efforts are expected to introduce next-generation stents, further expanding the market and offering tailored solutions for diverse patient needs.
• Rising Demand for Minimally Invasive Procedures: The shift towards minimally invasive vascular interventions is a significant growth factor. Iliac stenting offers a less traumatic alternative to open surgery, with shorter hospital stays and quicker recovery. Patients and clinicians prefer these procedures for their safety and convenience. As healthcare systems prioritize outpatient treatments, the demand for iliac stents increases, prompting manufacturers to develop user-friendly, cost-effective devices that support minimally invasive techniques.
• Expanding Healthcare Infrastructure and Access: Growing healthcare infrastructure, especially in emerging economies, improves access to vascular treatments. Investments in hospitals and specialized clinics facilitate the adoption of iliac stenting procedures. Government initiatives and public-private partnerships aim to enhance diagnostic and treatment facilities, broadening patient reach. This expansion supports market growth by enabling more widespread use of iliac stents, particularly in regions with previously limited access to advanced vascular care.
• Strategic Partnerships and Market Consolidation: Collaborations between device manufacturers, healthcare providers, and research institutions foster innovation and market expansion. Mergers and acquisitions consolidate market share, streamline product portfolios, and accelerate development of advanced stents. Strategic partnerships also facilitate clinical trials and regulatory approvals, boosting product credibility. These activities help companies penetrate new markets and meet evolving clinical demands, ensuring sustained growth and competitiveness in the iliac stent market.

The overall impact of these opportunities is a robust expansion of the iliac stent market, driven by technological innovation, increased disease prevalence, and improved healthcare access. Stakeholders who leverage these growth avenues can enhance treatment outcomes, expand their market presence, and meet the rising demand for minimally invasive vascular solutions. This evolving landscape promises sustained growth and innovation, shaping the future of vascular intervention therapies.

Iliac Stent Market Driver and Challenges

The iliac stent market is influenced by a variety of technological, economic, and regulatory factors that shape its growth trajectory. Advances in minimally invasive procedures and stent technology have increased the adoption of iliac stents worldwide. Economic factors such as rising healthcare expenditure and increasing prevalence of peripheral artery disease (PAD) further propel market expansion. Regulatory approvals and guidelines ensure safety and efficacy, fostering confidence among healthcare providers and patients. However, challenges like high costs, stringent regulatory processes, and technological limitations pose hurdles. Understanding these drivers and challenges is essential for stakeholders to navigate the evolving landscape and capitalize on emerging opportunities.

The factors responsible for driving the iliac stent market include:

• Technological Innovations: The development of advanced stent materials and designs, such as drug-eluting and bioresorbable stents, has significantly improved patient outcomes. These innovations reduce restenosis rates and enhance durability, making procedures more effective and appealing to clinicians. Continuous R&D efforts are leading to more precise, minimally invasive interventions, which expand the patient pool eligible for treatment. As technology advances, costs tend to decrease, further promoting adoption across various healthcare settings. The integration of imaging and navigation systems also enhances procedural accuracy, boosting confidence among practitioners and patients alike.
• Increasing Prevalence of Peripheral Artery Disease (PAD): The rising incidence of PAD, especially among aging populations and those with diabetes or hypertension, is a major growth driver. As PAD progresses, patients often require revascularization procedures, including iliac stent placement. The growing burden of cardiovascular diseases globally, coupled with lifestyle changes and urbanization, has led to increased diagnosis and treatment rates. This trend directly correlates with higher demand for minimally invasive solutions like iliac stents, fueling market expansion. Governments and healthcare providers are prioritizing early diagnosis and intervention, further supporting market growth.
• Favorable Reimbursement Policies: Improved reimbursement frameworks in many regions have made iliac stent procedures more accessible and affordable. Insurance coverage and government schemes reduce out-of-pocket expenses for patients, encouraging more individuals to seek treatment. Reimbursement policies that recognize the long-term cost savings of minimally invasive procedures over traditional surgery also incentivize healthcare providers to adopt iliac stents. This financial support accelerates market penetration, especially in emerging economies where cost barriers previously limited access. As reimbursement policies continue to evolve favorably, market growth is expected to accelerate further.
• Growing Healthcare Infrastructure: The expansion of healthcare infrastructure, particularly in developing countries, facilitates increased access to advanced vascular interventions. Investments in hospitals, clinics, and specialized vascular centers enable more patients to receive timely diagnosis and treatment. The availability of trained healthcare professionals and modern equipment supports the adoption of iliac stents. Additionally, collaborations between public and private sectors are improving healthcare delivery, making minimally invasive procedures more widespread. This infrastructure development not only boosts current market demand but also lays the foundation for sustained growth as awareness and accessibility increase.
• Rising Awareness and Screening Programs: Increased awareness about PAD and peripheral vascular diseases, along with widespread screening initiatives, has led to earlier diagnosis and intervention. Educational campaigns targeting high-risk populations promote understanding of treatment options, including iliac stents. Early detection allows for less invasive procedures, reducing complications and improving quality of life. The proliferation of screening programs in both developed and developing countries ensures a steady pipeline of patients eligible for stent placement. This heightened awareness directly correlates with increased procedure volumes, supporting overall market growth.

The challenges facing this iliac stent market include:

• High Cost of Devices and Procedures: The advanced technology involved in manufacturing iliac stents, especially drug-eluting and bioresorbable types, results in high device costs. Additionally, procedural expenses, including hospital stays and specialist fees, can be prohibitive for some patients and healthcare systems. This financial barrier limits access, particularly in low- and middle-income countries, restricting market growth. Reimbursement limitations and budget constraints further exacerbate the issue, making it difficult for providers to adopt the latest technologies widely. Overcoming cost-related challenges is crucial for expanding market reach and ensuring equitable access to treatment.
• Stringent Regulatory Environment: The approval process for new iliac stent devices involves rigorous testing and compliance with safety and efficacy standards set by regulatory authorities. Lengthy approval timelines and complex documentation requirements can delay product launches and market entry. Variability in regulations across regions adds complexity for manufacturers aiming for global distribution. These regulatory hurdles increase costs and time-to-market, potentially discouraging innovation and limiting product availability. Navigating this landscape requires significant resources and strategic planning, which can be challenging for smaller companies and startups.
• Technological Limitations and Complications: Despite advancements, certain limitations persist, such as stent thrombosis, restenosis, and device migration. These complications can lead to repeat procedures and adverse patient outcomes, impacting market confidence. Additionally, some patients may not be suitable candidates for stent placement due to anatomical or comorbid conditions. Technological limitations also include issues related to long-term durability and biocompatibility. Addressing these challenges requires ongoing research and development, which can be resource-intensive. Overcoming these limitations is essential for improving patient outcomes and expanding the market.

In summary, the iliac stent market is driven by technological innovations, increasing disease prevalence, supportive reimbursement policies, expanding healthcare infrastructure, and heightened awareness. However, high costs, regulatory complexities, and technological limitations pose significant challenges. These factors collectively influence market dynamics, with growth prospects hinging on the ability to address barriers and leverage opportunities. As technological and regulatory landscapes evolve, stakeholders must focus on cost reduction, innovation, and improved patient outcomes to sustain growth and competitiveness in this expanding market.

List of Iliac Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies iliac stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the iliac stent companies profiled in this report include-

• BD
• Abbott
• Boston Scientific Corporation
• W. L. Gore & Associates, Inc.
• Medtronic
• Cook
• Terumo Corporation
• iVascular
• Getinge AB
• Biotronik SE & Co KG

Iliac Stent Market by Segment

The study includes a forecast for the global iliac stent market by type, artery lesions, end use, and region.

Iliac Stent Market by Type [Value from 2019 to 2035]:

• Self-expandable Stents
• Balloon-expandable Stents
• Others

Iliac Stent Market by Artery Lesions [Value from 2019 to 2035]:

• Common Iliac Artery Lesions
• Severe Calcified Lesions
• Complete Obstructive Lesions

Iliac Stent Market by End Use [Value from 2019 to 2035]:

• Hospitals
• Outpatient Facilities
• Others

Iliac Stent Market by Region [Value from 2019 to 2035]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Iliac Stent Market

The iliac stent market has experienced significant growth driven by technological advancements, increasing prevalence of peripheral artery disease, and expanding healthcare infrastructure worldwide. Countries are adopting innovative stent designs and materials to improve patient outcomes, reduce complications, and enhance procedural success rates. Regulatory approvals and rising awareness about minimally invasive treatments are further propelling market expansion. Each country's unique healthcare policies, technological adoption, and patient demographics influence the pace and nature of developments in this sector. Understanding these regional trends is crucial for stakeholders aiming to capitalize on emerging opportunities and address unmet clinical needs effectively.

• United States: The US market has seen rapid adoption of drug-eluting iliac stents, driven by high healthcare expenditure and advanced medical infrastructure. Innovations such as bioresorbable stents and improved imaging techniques are gaining popularity. Regulatory agencies like the FDA are approving new devices that offer better flexibility and durability, enhancing patient outcomes. The increasing prevalence of peripheral artery disease among aging populations and rising awareness about minimally invasive procedures are key factors fueling growth. Additionally, collaborations between medical device companies and healthcare providers are fostering innovation and expanding access to advanced iliac stent options.
• China: China's iliac stent market is expanding due to rising cases of peripheral artery disease linked to increasing urbanization, sedentary lifestyles, and a growing aging population. The government's focus on healthcare reforms and expanding insurance coverage has improved access to vascular interventions. Local manufacturers are investing in R&D to develop cost-effective, high-quality stents tailored to regional needs. Technological adoption is accelerating, with a focus on minimally invasive procedures and improved device performance. The market is also benefiting from international collaborations and regulatory support, which facilitate the entry of advanced stent technologies into the Chinese healthcare system.
• Germany: Germany's market is characterized by high adoption of innovative stent technologies, supported by a well-established healthcare system and stringent regulatory standards. The focus is on developing durable, biocompatible, and customizable iliac stents to improve long-term patency rates. Germany's emphasis on research and development, along with collaborations between academic institutions and industry, drives technological advancements. The aging population and increasing prevalence of peripheral artery disease contribute to steady market growth. Moreover, Germany's strong emphasis on minimally invasive vascular procedures and patient safety standards ensures continuous demand for advanced iliac stent solutions.
• India: The Indian iliac stent market is witnessing rapid growth due to increasing cases of peripheral artery disease, driven by lifestyle changes and a rising diabetic population. The government's initiatives to improve healthcare infrastructure and affordability are facilitating wider access to vascular interventions. Local manufacturers are focusing on producing cost-effective stents that meet international quality standards, making advanced treatments more accessible. The adoption of minimally invasive techniques is increasing, supported by a growing number of trained specialists. Additionally, rising awareness and expanding healthcare coverage are expected to further propel market growth, with international companies entering the market through partnerships and regulatory approvals.
• Japan: Japan's iliac stent market is characterized by high technological sophistication and a focus on innovation. The country's aging population significantly contributes to the rising demand for vascular interventions. Japan's regulatory environment encourages the development and approval of advanced stent technologies, including drug-eluting and bioresorbable options. The market benefits from strong healthcare infrastructure, extensive clinical research, and a high prevalence of peripheral artery disease. Japanese manufacturers are investing in R&D to develop next-generation stents with improved biocompatibility and long-term durability. The integration of digital health tools and minimally invasive procedures continues to shape the evolving landscape of the iliac stent market in Japan.

Features of the Global Iliac Stent Market

• Market Size Estimates: Iliac stent market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2025) and forecast (2026 to 2035) by various segments and regions.
• Segmentation Analysis: Iliac stent market size by type, artery lesions, end use, and region in terms of value ($B).
• Regional Analysis: Iliac stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, artery lesions, end uses, and regions for the iliac stent market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the iliac stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the iliac stent market by type (self-expandable stents, balloon-expandable stents, and others), artery lesions (common iliac artery lesions, severe calcified lesions, and complete obstructive lesions), end use (hospitals, outpatient facilities, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 7 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Iliac Stent Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Self-expandable Stents : Trends and Forecast (2019-2035)
• 4.4 Balloon-expandable Stents : Trends and Forecast (2019-2035)
• 4.5 Others : Trends and Forecast (2019-2035)

5. Global Iliac Stent Market by Artery Lesions

• 5.1 Overview
• 5.2 Attractiveness Analysis by Artery Lesions
• 5.3 Common Iliac Artery Lesions : Trends and Forecast (2019-2035)
• 5.4 Severe Calcified Lesions : Trends and Forecast (2019-2035)
• 5.5 Complete Obstructive Lesions : Trends and Forecast (2019-2035)

6. Global Iliac Stent Market by End Use

• 6.1 Overview
• 6.2 Attractiveness Analysis by End Use
• 6.3 Hospitals : Trends and Forecast (2019-2035)
• 6.4 Outpatient Facilities : Trends and Forecast (2019-2035)
• 6.5 Others : Trends and Forecast (2019-2035)

7. Regional Analysis

• 7.1 Overview
• 7.2 Global Iliac Stent Market by Region

8. North American Iliac Stent Market

• 8.1 Overview
• 8.2 North American Iliac Stent Market by Type
• 8.3 North American Iliac Stent Market by End Use
• 8.4 The United States Iliac Stent Market
• 8.5 Canadian Iliac Stent Market
• 8.6 Mexican Iliac Stent Market

9. European Iliac Stent Market

• 9.1 Overview
• 9.2 European Iliac Stent Market by Type
• 9.3 European Iliac Stent Market by End Use
• 9.4 German Iliac Stent Market
• 9.5 French Iliac Stent Market
• 9.6 Italian Iliac Stent Market
• 9.7 Spanish Iliac Stent Market
• 9.8 The United Kingdom Iliac Stent Market

10. APAC Iliac Stent Market

• 10.1 Overview
• 10.2 APAC Iliac Stent Market by Type
• 10.3 APAC Iliac Stent Market by End Use
• 10.4 Chinese Iliac Stent Market
• 10.5 Indian Iliac Stent Market
• 10.6 Japanese Iliac Stent Market
• 10.7 South Korean Iliac Stent Market
• 10.8 Indonesian Iliac Stent Market

11. ROW Iliac Stent Market

• 11.1 Overview
• 11.2 ROW Iliac Stent Market by Type
• 11.3 ROW Iliac Stent Market by End Use
• 11.4 Middle Eastern Iliac Stent Market
• 11.5 South American Iliac Stent Market
• 11.6 African Iliac Stent Market

12. Competitor Analysis

• 12.1 Product Portfolio Analysis
• 12.2 Operational Integration
• 12.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

• 13.1 Value Chain Analysis
• 13.2 Growth Opportunity Analysis
  • 13.2.1 Growth Opportunity by Type
  • 13.2.2 Growth Opportunity by Artery Lesions
  • 13.2.3 Growth Opportunity by End Use
• 13.3 Emerging Trends in the Global Iliac Stent Market
• 13.4 Strategic Analysis
  • 13.4.1 New Product Development
  • 13.4.2 Certification and Licensing
  • 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

• 14.1 Competitive Analysis Overview
• 14.2 BD
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.3 Abbott
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.4 Boston Scientific Corporation
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.5 W. L. Gore & Associates, Inc.
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.6 Medtronic
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.7 Cook
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.8 Terumo Corporation
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.9 iVascular
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.10 Getinge AB
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 14.11 Biotronik SE & Co KG
  • Company Overview
  • Iliac Stent Market Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

15. Appendix

• 15.1 List of Figures
• 15.2 List of Tables
• 15.3 Research Methodology
• 15.4 Disclaimer
• 15.5 Copyright
• 15.6 Abbreviations and Technical Units
• 15.7 About Us
• 15.8 Contact Us